Dhawale Kasturi K, Tidake Pravin
Ophthalmology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus. 2024 Jul 24;16(7):e65236. doi: 10.7759/cureus.65236. eCollection 2024 Jul.
Glaucoma, a leading cause of blindness globally, necessitates effective management strategies to prevent irreversible vision loss. Traditional glaucoma surgeries, while effective, are associated with significant risks and complications. Minimally invasive glaucoma surgery (MIGS) has emerged as a transformative approach, offering safer and less invasive alternatives. This review provides a comprehensive overview of recent advancements in MIGS, highlighting current trends, technological innovations, and future directions. MIGS procedures, characterized by smaller incisions and quicker recovery times, have expanded the therapeutic landscape, enabling earlier intervention and improved patient outcomes. The review evaluates various MIGS techniques, their efficacy, safety profiles, and clinical outcomes, drawing insights from comparative studies and meta-analyses. Technological innovations, including enhanced device designs and integration with digital health technologies, have further bolstered the field. Despite challenges in patient selection and long-term outcomes, the future of MIGS is promising, with ongoing research and development poised to enhance its impact. By synthesizing the latest research, this review aims to inform clinicians, researchers, and policymakers, ultimately contributing to improved management of glaucoma and patient care.
青光眼是全球失明的主要原因之一，需要有效的管理策略来防止不可逆转的视力丧失。传统的青光眼手术虽然有效，但存在重大风险和并发症。微创青光眼手术（MIGS）已成为一种变革性方法，提供了更安全、侵入性更小的替代方案。本文综述全面概述了MIGS的最新进展，突出了当前趋势、技术创新和未来方向。MIGS手术以切口更小、恢复时间更快为特点，拓展了治疗领域，实现了更早的干预并改善了患者预后。该综述评估了各种MIGS技术、其疗效、安全性和临床结果，从比较研究和荟萃分析中获取见解。技术创新，包括改进的设备设计以及与数字健康技术的整合，进一步推动了该领域的发展。尽管在患者选择和长期结果方面存在挑战，但MIGS的未来充满希望，正在进行的研发有望增强其影响力。通过综合最新研究，本综述旨在为临床医生、研究人员和政策制定者提供信息，最终有助于改善青光眼的管理和患者护理。
